NCT03305367View on ClinicalTrials.gov

Dose-response Effect of Pine Nut Oil as a Dual FFA1 and FFA4 Agonist on Glucose Tolerance in Healthy Humans.

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 6, 2017

Primary Completion Date

August 23, 2017

Study Completion Date

August 23, 2017

Conditions
Type 2 Diabetes Mellitus
Interventions
DIETARY_SUPPLEMENT

Hydrolyzed pine nut oil

Randomized cros-over intervention of 3 OGTT with no oil, low dose or high dose.

Trial Locations (1)

5000

Department of Endocrinology, Odense

All Listed Sponsors
collaborator

University of Southern Denmark

OTHER

lead

Odense University Hospital

OTHER

NCT03305367 - Dose-response Effect of Pine Nut Oil as a Dual FFA1 and FFA4 Agonist on Glucose Tolerance in Healthy Humans. | Biotech Hunter | Biotech Hunter